BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 26/06/2009

FDA Approves New Dosage of Trilostane for Dogs with Hyperadrenocorticism

The US Food and Drug Administration (FDA) has amended its animal drug regulations to include a new dosage of trilostane, a medication used to treat hyperadrenocorticism in dogs, following a supplemental approval by Dechra, Ltd.

Source: Federal Register — Food and Drug AdministrationOpen original release →